Does perioperative therapy and surgery have a role in stage III NSCLC?

Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLCПодробнее

Dr. Mason on the Role of Surgery in Stage III NSCLCПодробнее

Surgical perspective on neoadjuvant IO for resectable stage III NSCLCПодробнее

Perioperative therapies in NSCLCПодробнее

Perioperative Versus Preoperative Surgery in NSCLC - OncTalk Lung 2023Подробнее

Debate: Surgery for stage IIIa patients with lung cancer? - YesПодробнее

Is there a role for surgery in stage 3A Lung Cancer?Подробнее

Are We Closer to a Cure With Perioperative Immunotherapy in Resectable NSCLC?Подробнее

Is perioperative therapy the best strategy for early stage lung cancer?Подробнее

Dr. Mason on Standard Treatment Approaches in Stage III NSCLCПодробнее

Stage III NSCLC Progression Treatment StrategyПодробнее

Stage 3 and Stage 4 Lung CancerПодробнее

Treating Unresectable Stage III NSCLC: A Focus on Stage IIIA DiseaseПодробнее

Perioperative Therapy in Early Stage NSCLC-Implications for Molecular TestingПодробнее

ASCO Lung Cancer Highlights, Part 4: Exploring the Role of Trimodality Therapy for Stage III NSCLCПодробнее

Defining Resectability in Stage IIIA Lung CancerПодробнее

Hope for Stage III Lung Cancer - State of HealthПодробнее

Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative SettingsПодробнее

SQUAT: neoadjuvant chemo-immuno-radiation and surgery in NSCLCПодробнее